Differences in Length of Hospitalization in Pneumonia patients Receiving Monotherapy and Polytherapy Empirical Antibiotic: Study at Tertiary Referral Hospital, Bali
- 7 May 2025
- journal article
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (5) , 2121-2126
Abstract
Community acquired pneumonia is one of the infectious diseases of the lungs with high morbidity and mortality rates. Rapid empirical antibiotic administration is needed to overcome this. Length of stay is one of the clinical outcomes in community acquired pneumonia, but until now there is no clear data related to the length of stay associated with the number of empirical antibiotics given to community acquired pneumonia patients. This study aims to see the difference in the length of stay between monotherapy and polytherapy patients. The research method used was descriptive analytic with a cross-sectional approach with the study sample including patients with a diagnosis of community acquired pneumonia and hospitalized who met the inclusion and exclusion criteria. Data collection was taken from medical record data in one of public hospital Bali in 2019. The collected data were analyzed univariately and bivariately. The results obtained from this study were that there was no difference in the median length of stay between monotherapy and polytherapy patients, both of which had a median of 5 days, while significant differences (p=0.01) were seen in the mean length of hospitalization between patients with monotherapy (4.88±2.14) and polytherapy (7.09±3.39) tested by the mann whitney. Further research is needed to clarify the relationship between the addition of empirical antibiotics and length of stay community pneumonia patients.Keywords
This publication has 26 references indexed in Scilit:
- Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical OpportunitiesCirculation Research, 2023
- Profil Pasien dengan Pneumonia Komunitas yang Dirawat di RSUD Wangaya Denpasar pada Bulan Oktober 2019 - Desember 2019E-Jurnal Medika Udayana, 2022
- Therapeutic Response of Community Acquired Pneumonia in Geriatrics: A Case Series from Intensive Care UnitIndonesian Journal of Clinical Pharmacy, 2021
- Comparison between monotherapy and combination therapy among inpatients with community-acquired pneumoniaJurnal Ilmiah Farmasi, 2021
- Profil Pasien dan Penggunaan Antibiotik pada Kasus Community-Acquired Pneumonia Rawat Inap di Rumah Sakit Akademik wilayah SukoharjoJPSCR: Journal of Pharmaceutical Science and Clinical Research, 2020
- Analisa Perbandingan Monoterapi dengan Dualterapi Antibiotik Empiris terhadap Outcome pada Pasien Community Acquired Pneumonia (CAP) di IGD RSUP Fatmawati JakartaJurnal Sains Farmasi & Klinis, 2019
- Sex differences in immune responsesNature Reviews Immunology, 2016
- Geriatric Medicine, Sarkopenia, Frailty, dan Kualitas Hidup Pasien Usia Lanjut: Tantangan Masa Depan Pendidikan, Penelitian dan Pelayanan Kedokteran di IndonesiaeJournal Kedokteran Indonesia, 2014
- Combination antibiotic therapy for community-acquired pneumoniaAnnals of Intensive Care, 2011
- Community-Acquired Pneumonia in Elderly PatientsAging Health, 2009